Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

IND accepted for phase I study of CPP-109 for treating cocaine addition

Jan. 10, 2005

USAMRIID awards grant to Lexicon for ricin biodefense efforts

Jan. 4, 2005

Standard and novel mGluR5 antagonists in the treatment of cocaine addiction

Jan. 3, 2005

Finasteride tested to treat alcoholism

Dec. 30, 2004

5-HT1B receptors are involved in cocaine sensitization

Dec. 28, 2004

ICL-670 effective in treating iron overload

Dec. 16, 2004

Aerosolized Radilex superior to muscle injection following radiation exposure

Dec. 15, 2004

Buprenorphine analogue inhibits morphine-induced behavioral sensitization in mice

Dec. 10, 2004

RiVax, first ricin vaccine to enter human clinical trials

Dec. 2, 2004

Tetrodin studied in phase II trial of opiate-dependent subjects

Nov. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...